Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
384,509,293
-
Number of holders
-
942
-
Total 13F shares, excl. options
-
246,506,415
-
Shares change
-
-2,035,906
-
Total reported value, excl. options
-
$29,955,571,272
-
Value change
-
-$272,422,709
-
Put/Call ratio
-
115%
-
Number of buys
-
366
-
Number of sells
-
-492
-
Price
-
$121.50
Significant Holders of Moderna, Inc. - COMMON STOCK (MRNA) as of Q2 2023
1,147 filings reported holding MRNA - Moderna, Inc. - COMMON STOCK as of Q2 2023.
Moderna, Inc. - COMMON STOCK (MRNA) has 942 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 246,506,415 shares
of 384,509,293 outstanding shares and own 64% of the company stock.
Largest 10 shareholders include BAILLIE GIFFORD & CO (45,711,095 shares), VANGUARD GROUP INC (27,462,437 shares), BlackRock Inc. (24,163,711 shares), STATE STREET CORP (14,227,227 shares), Flagship Pioneering Inc. (12,886,743 shares), COATUE MANAGEMENT LLC (6,546,104 shares), GEODE CAPITAL MANAGEMENT, LLC (6,302,497 shares), Theleme Partners LLP (6,246,499 shares), MORGAN STANLEY (5,817,085 shares), and WELLINGTON MANAGEMENT GROUP LLP (5,134,918 shares).
This table shows the top 942 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.